Form 8-K Kinnate Biopharma Inc. For: Jan 09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/24/2026
- Wall St futures retreat as oil gains on Mideast uncertainty, eyes on Trump-Xi talks
- Oil gains on little sign of progress in US-Iran talks
- S&P 500 history shows strong gains across Fed hiking cycles: BCA
- JPMorgan upgrades CoreWeave on stronger compute pricing
- BTIG’s Krinsky warns 2000-like signals are mounting
- Plug Power COO resigns to join another company
- Wall Street ends down as oil prices, Treasury yields rise
- Anthropic's Claude AI identifies novel enzyme system in DNA search
- AppLovin (APP) on watch amid 3% drop premarket as boutique comments circulate
- Xtend AI Robotics wins Phase III of USSOCOM lethal drone program
Kinnate Biopharma (KNTE) to Cut 56% Staff
January 16, 2024 4:08 PM ESTOn January 9, 2024, Kinnate Biopharma (NASDAQ: KNTE) committed to implement a further workforce reduction (the RIF) pursuant to which the Company will reduce its workforce by approximately 56% to a total of 12 remaining full-time employees. The RIF is being implemented in connection with a process the Company... More
